Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Logicbio Therapeutics Inc (LOGC)

Logicbio Therapeutics Inc (LOGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Logicbio Therapeutics Inc 65 HAYDEN AVENUE 2ND FLOOR LEXINGTON MA 02421 USA

www.logicbio.com P: 617-245-0399

Description:

LogicBio Therapeutics Inc. is a genome editing company. It focuses on developing medicines to treat rare diseases in patients with significant unmet medical needs. The company's technology platform consists of GeneRide(TM). LogicBio Therapeutics Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 68,233
Enterprise Value, $K 23,063
Shares Outstanding, K 32,963
Annual Sales, $ 5,410 K
Annual Net Income, $ -40,030 K
Last Quarter Sales, $ 3,200 K
Last Quarter Net Income, $ -5,040 K
60-Month Beta 4.61
% of Insider Shareholders 8.10%
% of Institutional Shareholders 39.11%
Float, K 30,293
% Float 91.90%
Short Volume Ratio 0.03

Growth:

1-Year Return -41.19%
3-Year Return -76.34%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 11/14/22
Latest Earnings Date 11/21/22
Earnings Per Share ttm -0.94
EPS Growth vs. Prev Qtr -20.00%
EPS Growth vs. Prev Year 41.94%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LOGC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -104.29%
Return-on-Assets % -49.25%
Profit Margin % -739.93%
Debt/Equity 0.17
Price/Sales 12.55
Price/Cash Flow N/A
Price/Book 4.34
Book Value/Share 0.63
Interest Coverage -36.44
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar